We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

28 hedge funds and large institutions have $10.5M invested in Axcella Health Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 2928 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

56% less capital invested

Capital invested by funds: $23.6M → $10.5M (-$13.1M)

89% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
1
Reduced
9
Closed
4
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$1K

AXLA Hedge Fund Activity: Q2 2023 in Review

28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2023, worth a combined $10.5M — down 56% from $23.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AXLA and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $9.42K. The largest seller was Fidelity Investments, cutting an estimated $285K.

  • 28 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2023, down from 29 in Q1 2023.
  • Funds reported $10.5M of Axcella Health Inc. Common Stock stock for Q2 2023, down 56% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -1 holder.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2023 was Morgan Stanley, an estimated $9.42K added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2023 was Fidelity Investments, an estimated $285K sold.

Based on aggregated 13F filings for Q2 2023.